测量生存模型的性能,以个性化治疗选择
Orestis Efthimiou1,2, Jeroen Hoogland3, Thomas P A Debray4
1Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Statistics in medicine
|April 10, 2025
概括
这项研究引入了新的指标,以评估统计和机器学习模型如何准确地预测临床试验中的个人患者治疗效益与生存结果.
科学领域:
- 生物统计学 生物统计学
- 医疗保健中的机器学习
- 临床试验分析
背景情况:
- 从随机临床试验 (RCT) 中预测患者一级的治疗效果有助于个性化医疗.
- 评估预测准确性的现有方法是有限的,特别是对于生存结果.
研究的目的:
- 扩展现有的评估参与者级治疗益处预测准确性的方法.
- 为在生存分析中估计治疗益处的模型提出新的性能测量措施.
主要方法:
- 在参与者层面定义的治疗效益.
- 总结了模型性能评估的现有和拟议的新指标.
- 探索了歧视,校准,效益和决策准确性的指标.
主要成果:
- 开发和说明了用于评估治疗效应预测模型的新型指标.
- 从OPERAM试验中使用模拟数据和真实世界的数据来证明实用性.
- 提供了实施拟议模型和措施的R代码.
结论:
- 拟议的指标增强了用于个性化治疗效果预测的统计和机器学习模型的评估.
- 这些措施对于模型开发,内部验证和生存分析中的外部验证有价值.
- 在临床实践中促进更准确的个性化治疗决策.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
92
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
92
Cancer Survival Analysis
308
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
308
Kaplan-Meier Approach
60
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
60
Survival Curves
75
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
75
Introduction To Survival Analysis
129
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
129
Actuarial Approach
49
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
49


